[×ÊÔ´] £Û×ÊÔ´£ÝÓйؽ¡¿µµÄÔ­°æÊé Health Care Matters£ÛÒÑËÑË÷£¬ÎÞÖظ´£Ý

ÕÒ²»µ½ºÍÄúµÄ²éѯ "Óйؽ¡¿µµÄÔ­°æÊé Health Care Matters.pdf" Ïà·ûµÄÍøÒ³¡£ LIST OF ILLUSTRATIONS vii ACKNOWLEDGMENTS ix 1 INTRODUCTION 1 2 LITERATURE REVIEW 5 Conclusions from Our Earlier Literature Review 5 Our Earlier Work 7 Recent Aggregate Studies of the Production of Health 9 Studies within the United States 9 International Studies 10 Epidemiological Studies of Risk Factors 13 Obesity 14 Other Studies of the Productivity of Pharmaceuticals 17 3 EXTENDING OUR EARLIER WORK ON PHARMACEUTICAL CONSUMPTION 19 Quality of Life 20 Cause-Specific Mortality 21 4 MODELING THE PRODUCTION OF HEALTH 24 Our Model 24 Data Sources 25 Health Indicators 25 Medical-Care Inputs 27 Measuring Pharmaceutical Consumption 28 Other Explanatory Variables 30 The Model Specification and Estimation 31 5 RESULTS 34 Descriptive Statistics 34 vi HEALTH CARE MATTERS Empirical Results for Disability-Adjusted and Unadjusted Life Expectancy 37 The Effects of Lifestyle and Wealth 37 The Effect of Nonpharmaceutical Medical-Care Consumption 39 The Effect of Pharmaceutical Consumption 40 Empirical Results for Circulatory Disease Mortality 45 The Effects of Lifestyle and Wealth 45 The Effect of Nonpharmaceutical Medical-Care Consumption 47 The Effect of Pharmaceutical Consumption 47 Empirical Results for Cancer Mortality 50 The Effects of Lifestyle and Wealth 50 The Effect of Nonpharmaceutical Medical-Care Consumption 51 The Effect of Pharmaceutical Consumption 52 Empirical Results for Respiratory Disease Mortality 53 The Effects of Lifestyle and Wealth 53 The Effect of Nonpharmaceutical Medical-Care Consumption 55 The Effect of Pharmaceutical Consumption 55 Sensitivity Testing 57 6 CONCLUSION 59 APPENDIX 63 NOTES 69 REFERENCES 71 INDEX 75 ABOUT THE AUTHORS 81 ²»Ðí×øɳ·¢ Ö»Ðí×ø°åµÊ [ Last edited by telomerase on 2007-5-23 at 22:24 ]

»Ø¸´´ËÂ¥